Capital Goods Healthcare Sector

Cardiogeni

Market Cap: UK£5.0m

A clinical stage biotechnology company, develops heart failure medicines.

Glow Lifetech

Market Cap: CA$9.4m

A biotechnology company, focuses on producing nutraceutical and cannabinoid-based products.

Xylo Technologies

Market Cap: US$6.8m

A technology-based company, provides medical-related devices and products in the United States, Europe, Asia, Israel, and internationally.

Sintx Technologies

Market Cap: US$6.7m

An advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States.

Universal Ibogaine

Market Cap: CA$9.3m

A life sciences company, develops, acquires, and operates addiction treatment clinics in Canada.

Khiron Life Sciences

Market Cap: CA$9.3m

Operates as an integrated medical and cannabis company in Latin America and Europe.

Nextleaf Solutions

Market Cap: CA$9.2m

A cannabis extraction technology company, engages in the manufacture and distribution of cannabinoid vapes, oils, and softgels in Canada.

Kane Biotech

Market Cap: CA$9.2m

A biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally.

Impact BioMedical

Market Cap: US$6.6m

Impact BioMedical Inc. discovers, develops, and commercializes products and technologies to address unmet needs in human healthcare and wellness for specialty biopharmaceuticals, antivirals, antimicrobials, consumer healthcare, and wellness products in the United States.

Genprex

Market Cap: US$6.6m

A clinical-stage gene therapy company, focuses on developing gene-based therapies for patient populations with unmet medical needs.

CordovaCann

Market Cap: US$6.6m

Engages in identifying, funding, developing, and managing operations in the cannabis value chain business.

National Graphite

Market Cap: US$6.6m

Through its subsidiary, Biotech Development Corp., operates as a biopharmaceutical risk/cost-sharing company.

Ontrak

Market Cap: US$6.6m

Operates as a value-based behavioral healthcare company in the United States.

Avant Brands

Market Cap: CA$9.1m

Avant Brands Inc. cultivates, produces, markets, and sells cannabis products in Canada.

Algorae Pharmaceuticals

Market Cap: AU$10.1m

A pharmaceutical development company, engages in the research and development of living cells technologies primarily in New Zealand.

ALR Technologies SG

Market Cap: US$6.5m

A data management company, provides diabetes care management solutions for human and animal health diabetes.

Memphasys

Market Cap: AU$9.9m

Develops, manufactures, and sells cell and protein separation devices, and related consumables for the healthcare, veterinary, and biotechnology market sectors in Australia.

Mountain Valley MD Holdings

Market Cap: CA$8.8m

Through its subsidiary, Mountain Valley MD Inc., operates as a health and wellness company in Canada.

AIM ImmunoTech

Market Cap: US$6.4m

An immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States.

Aptorum Group

Market Cap: US$6.3m

Through its subsidiaries, a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products to treat oncology and infectious diseases.

HeraMED

Market Cap: AU$9.6m

A medical data and technology company, develops, manufactures, and sells home-based maternity monitoring technology in Australia and the United States.

Enzon Pharmaceuticals

Market Cap: US$6.2m

Does not have significant operations.

ProText Mobility

Market Cap: US$6.2m

A biotech company, engages in the development of pharmaceutical botanical medicines.

ARCpoint

Market Cap: CA$8.4m

Provides franchise systems offering drug, alcohol, DNA, and clinical lab testing and screening services in the United States.

AppYea

Market Cap: US$6.1m

A digital health company, develops wearable monitoring solutions to treat sleep apnea and snoring.

Acrux

Market Cap: AU$9.4m

Engages in the development and commercialization of generic and topically applied pharmaceutical products in Australia, Europe, the United States, and internationally.

Lyra Therapeutics

Market Cap: US$6.1m

A clinical-stage biotechnology company, focuses on the development and commercialization of anti-inflammatory therapies for the treatment of patients with chronic rhinosinusitis.

Veltex

Market Cap: US$6.1m

Focuses on the development and acquisition of companies that have modalities in the areas of health, wellness, and recovery.

Cann Group

Market Cap: AU$9.3m

Engages in the breeding, cultivating, manufacturing, and selling medicinal cannabis in Australia and Europe.

AEON Biopharma

Market Cap: US$6.0m

A clinical stage biopharmaceutical company, focuses on developing botulinum toxins.

Sentient Brands Holdings

Market Cap: US$6.0m

A product development and brand management company, builds brands in the luxury and premium market space.

GENinCode

Market Cap: UK£4.4m

Develops and commercializes clinical genetic tests to provide predictive analysis of risk to a patient’s health based on their genes in the United Kingdom and internationally.

CNS Pharmaceuticals

Market Cap: US$6.0m

A clinical pharmaceutical company, develops anti-cancer drug candidates for the treatment of brain and central nervous system tumors.

Incannex Healthcare

Market Cap: US$6.0m

A clinical-stage biopharmaceutical company, engages in the research, development, manufacture, sale, and distribution of psychedelic medicines and therapies for patients with chronic diseases in Australia.

SunLink Health Systems

Market Cap: US$6.0m

Through its subsidiaries, provides healthcare products and services in the southeastern United States.

Bionoid Pharma

Market Cap: US$5.9m

Engages in the hemp cultivation business.